ATE136940T1 - Diagnostische methode - Google Patents
Diagnostische methodeInfo
- Publication number
- ATE136940T1 ATE136940T1 AT93916109T AT93916109T ATE136940T1 AT E136940 T1 ATE136940 T1 AT E136940T1 AT 93916109 T AT93916109 T AT 93916109T AT 93916109 T AT93916109 T AT 93916109T AT E136940 T1 ATE136940 T1 AT E136940T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- sec
- diagnostic method
- date
- date apr
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70585—CD44
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929215498A GB9215498D0 (en) | 1992-07-21 | 1992-07-21 | Diagnostic method |
GB929224386A GB9224386D0 (en) | 1992-11-20 | 1992-11-20 | Nucleic acid sequence |
GB929226165A GB9226165D0 (en) | 1992-12-16 | 1992-12-16 | Nucleic acid sequence |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE136940T1 true ATE136940T1 (de) | 1996-05-15 |
Family
ID=27266293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93916109T ATE136940T1 (de) | 1992-07-21 | 1993-07-20 | Diagnostische methode |
Country Status (7)
Country | Link |
---|---|
US (1) | US5830646A (de) |
EP (1) | EP0651822B1 (de) |
JP (1) | JP2800850B2 (de) |
AT (1) | ATE136940T1 (de) |
CA (1) | CA2139410A1 (de) |
DE (1) | DE69302276T2 (de) |
WO (1) | WO1994002633A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08511624A (ja) * | 1993-06-22 | 1996-12-03 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 腫瘍の診断方法及び分析方法 |
GB9317139D0 (en) * | 1993-08-18 | 1993-10-06 | Miniser For Agriculture Fisher | Method and test kits for detection of bacteriophage |
DE4431297A1 (de) * | 1994-09-02 | 1996-03-07 | Boehringer Ingelheim Int | Monoklonaler Antikörper gegen CD44v6 |
JPH10504188A (ja) * | 1994-07-21 | 1998-04-28 | アイシス・イノベーション・リミテッド | 診断方法およびプローブ |
DE19545472A1 (de) * | 1995-12-06 | 1997-06-12 | Boehringer Ingelheim Int | Verfahren zur Diagnose und Therapie von Plattenepithelkarzinomen |
DE19653607A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Int | Verfahren zur Diagnose und Therapie von Hodgkin-Lymphomen |
WO1999004036A1 (en) * | 1997-07-14 | 1999-01-28 | Isis Innovation Limited | Cd44 based cancer detection |
US20030170637A1 (en) * | 2002-03-06 | 2003-09-11 | Pirrung Michael C. | Method of analyzing mRNA splice variants |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4014510A1 (de) * | 1990-05-07 | 1991-11-14 | Kernforschungsz Karlsruhe | Variante cd44-oberflaechenproteine, diese kodierende c-dna-sequenzen, antikoerper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie |
EP0551301A1 (de) * | 1990-07-13 | 1993-07-21 | The General Hospital Corporation | Zelloberflächenantigen cd53 und verwendungen |
-
1993
- 1993-07-20 JP JP6504278A patent/JP2800850B2/ja not_active Expired - Lifetime
- 1993-07-20 WO PCT/GB1993/001520 patent/WO1994002633A1/en not_active Application Discontinuation
- 1993-07-20 CA CA002139410A patent/CA2139410A1/en not_active Abandoned
- 1993-07-20 EP EP93916109A patent/EP0651822B1/de not_active Revoked
- 1993-07-20 DE DE69302276T patent/DE69302276T2/de not_active Revoked
- 1993-07-20 US US08/373,284 patent/US5830646A/en not_active Expired - Fee Related
- 1993-07-20 AT AT93916109T patent/ATE136940T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH08500731A (ja) | 1996-01-30 |
DE69302276D1 (de) | 1996-05-23 |
US5830646A (en) | 1998-11-03 |
EP0651822A1 (de) | 1995-05-10 |
DE69302276T2 (de) | 1996-09-19 |
JP2800850B2 (ja) | 1998-09-21 |
EP0651822B1 (de) | 1996-04-17 |
CA2139410A1 (en) | 1994-02-03 |
WO1994002633A1 (en) | 1994-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0554383A4 (de) | ||
DE69531457D1 (en) | Sulfonamide | |
DE69508192D1 (de) | Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen | |
GR3031488T3 (en) | Laminin chains: diagnostic and therapeutic use | |
ATE311150T1 (de) | Medizinisches instrument zur behandlung von biologischem gewebe sowie verfahren zum übertragen von druckwellen | |
AU2738195A (en) | Tumor diagnosis and prognosis | |
ATE321570T1 (de) | Verfahren zur behandlung von hämostatischen störungen durch lösliches p-selectin | |
ATE223051T1 (de) | Verfahren zur diagnose gutartiger prostataerkrankungen | |
Kennett et al. | Investigations into the cellular contribution to host tissue proteases and inhibitors in gingival crevicular fluid | |
DE69302276D1 (de) | Diagnostische Methode | |
DE69624369D1 (de) | Schutzhülle für eine sonde | |
AU7635396A (en) | Treatment and diagnosis of infections due to helicobacter pylori | |
FI954499A (fi) | Menetelmä ja analyysi | |
EP0535059B1 (de) | Dna-sequenz für eine serin-protease und damit zusammenhängende gegenstände | |
MACKIE et al. | A case of pagetoid reticulosis bearing the T cytotoxic suppressor surface marker on the lymphoid infiltrate: further evidence that pagetoid reticulosis is not a variant of mycosis fungoides | |
HK1002531A1 (en) | New tumor diagnosing or therapeutical probe | |
DE69226775D1 (de) | Dns-sequenzen von hpv42 papillomavirus :verwendungsmöglichkeit für diagnose | |
DE69517191D1 (de) | Wasserlösliche derivate epipodophyllotoxine, verfahren zu ihrer herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels | |
Sharpe | Gender role and psychological well-being in adult men. | |
ATE222762T1 (de) | 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus | |
ATE240352T1 (de) | Komplexverbindungen zur diagnose von gefässerkrankungen | |
AU8144894A (en) | Biphenyl iodinated derivatives and their diagnostic use | |
Owen | Improved in vitro determination of the viability of Taenia saginata embryos | |
DE4291352D2 (de) | Verfahren zur Diagnose von nicht-Insulin-abhänigigem Diabetes mellitus | |
ATE420210T1 (de) | Diagnose des brustkrebsrisikos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
RZN | Patent revoked |